This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Dermatologic Disorders  • Bullous Diseases  • Pemphigus  • Immunologic Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

David L. Crosby, MD
Waukesha, Wis

Arch Dermatol. 1999;135:947.

	Since this article does not have an abstract, we have provided the first 75 words of the full text and any section headings.

This study presents an evolving technology in the evaluation and diagnosis of autoimmune diseases. Enzyme-linked immunosorbent assay with specific recombinant target antigens, rather than the less specific immunofluorescence studies that most clinicians rely on to diagnose autoimmune bullous diseases, is used by these investigators to study a unique form of pemphigus. Enzyme-linked immunosorbent assay may be a more cost-effective and specific replacement for immunofluorescence in the future diagnosis of autoimmune disease.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Desmoglein 1 and Desmoglein 3 Are the Target Autoantigens in Herpetiform Pemphigus
Ken Ishii, Masayuki Amagai, Ayako Komai, Tamotsu Ebihara, Tadeusz P. Chorzelski, Stefania Jablonska, Kazuhiko Ohya, Takeji Nishikawa, and Takashi Hashimoto
Arch Dermatol. 1999;135(8):943-947.
ABSTRACT | FULL TEXT